Trial | NCT03680027  Report issue

Title

Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects: A Randomized-Controlled Trial: A Randomized-Controlled Trial

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    37
Walnuts have been shown to reduce serum lipids in hyperlipidemic individuals with a well-controlled feeding trials. Current study have been determined the effects of daily walnut consumption on serum lipids, fasting glucose and insulin levels in hyperlipidemic individuals.
In this, randomized controlled trial, mild to moderate hyperlipidemic subjects were randomly divided into 2 groups as walnut-enriched (n=20) and control (n=17) groups for 6 weeks. All subjects adhered to a medical nutrition therapy as low-fat and low-cholesterol diet. The walnut-enriched group was supplemented with 40 g/day of walnuts added to their diets. In order to follow nutritional status of subjects, they were visited every 15 days (in total 4 times). Anthropometric measurements of the subjects were taken and were monitored at each visit during the study. Blood samples were measured at the beginning and again at the end of the study.
Study Started
Jul 10
2015
Primary Completion
Aug 27
2015
Study Completion
Sep 30
2015
Last Update
Sep 24
2018

Dietary Supplement Walnut-enriched Group

All subjects supplemented with 40 g/day of walnuts for 6 weeks.

Control Group No Intervention

In 'Control group' participants had 6 week follow-up without any intervention.

Interventional Group Experimental

In 'Interventional group' participants had 6 week follow-up and during that period of time, they were asked to consume 40g/day walnut. Participants in intervention group was ensured to consume all 40g of walnut every day, during their snack times for 6 weeks.

Criteria 

Inclusion Criteria:

Hyperlipidemic patients who are not using any lipid lowering medications
Non-smoker
No alcohol consumption
Individuals who are having ≤30kg/m2
Individuals who do not have any allergy for nut consumption
Female participants who are not pregnant or breastfeeding
Individuals should not be in a weight loss programme
Having not consumed regular nuts for the last 1 month,
Except hypertension, they should not have other chronic diseases (such as diabetes, chronic renal failure)
No intense exercise

Exclusion Criteria:

Failure to meet the criteria for inclusion criteria.
No Results Posted